Welcome

Welcome!

We're a few months into the new year and it seems we're already in high gear here at the European Prevention of Alzheimer's Dementia (EPAD) project. Continuous collaborative efforts in our EPAD family have brought us to a point that allows me to proudly announce that we are on the verge of recruiting our first Research Participant into the EPAD Longitudinal Cohort Study (LCS). This European-wide study is dedicated to improve our understanding of the early stages of the disease and identify a window of opportunity for effective intervention. We cannot do this alone, we need your help - together as a team!

This electronic newsletter will be published quarterly and be accessible via the EPAD website (www.ep-ad.org) and inform the Alzheimer community on EPAD’s main achievements, upcoming events as well as allow you to meet the scientists who make it all happen.

In this issue, the project highlights of Q1 2016 are presented. You can also find out more about 2 of the EPAD collaborators, Gloria Oliver Rodriguez and Gerald Luscan.

We hope you enjoy this issue of the EPAD newsletter! Happy Reading! 

Craig Ritchie

EPAD Coordinator

Q1 2016 Highlights

Working Together towards the Longitudinal Cohort Study (LCS) Start-up!

The first quarter of 2016 started with great intensity! We were busy working towards recruiting the very first research participant into our study and should reach this important milestone early next month. A serious engagement of the entire EPAD family was also needed for the mandatory scientific and financial progress report to the Innovative Medicines Initiative. Here are some …

Read more.

Interview with Gerald Luscan

What is your current role in EPAD? In EPAD, I am co-leading the WP3 (EPAD register and Parent Cohorts) with Dr. Pieter Jelle Visser. I also represent WP3 on the Steering committee and the Data Oversight Committee. I am lucky to have many talented people in WP3 with different expertise.  My role is to organize interactions within WP3 and also …

Read more.

EPAD presents @

• The Alzheimer’s Association International Conference at the Alzheimer’s Association International Conference. July 24-28. Toronto, Canada. The application for a Featured Research Session featuring GAP and EPAD has been accepted at AAIC with the following topic: Speeding Innovative Medicines to Those in Need: The Global Alzheimer’s Platform.

• A summary of the 2015 EPAD Achievements has been submitted to IMI for inclusion in the IMI Alzheimer Factsheet and will be published soon.